Nosa Med AB (ST:NOSA) — Stock Price

Skr0.50 SEK
▲ 3.44% today

Nosa Med AB (ST:NOSA) is currently trading at Skr0.50 SEK, up 3.44% today. Over the past 52 weeks, shares have ranged between Skr0.48 and Skr0.85. This page tracks Nosa Med AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see NOSA stock market capitalisation.

Nosa Med AB (NOSA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Nosa Med AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Nosa Med AB Income Statement — Revenue, Profit & Earnings by Year

Nosa Med AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr23.91 Million Skr16.10 Million Skr10.39 Million Skr6.85 Million Skr5.85 Million
Cost of Revenue Skr31.94 Million Skr4.90 Million Skr3.47 Million Skr2.08 Million Skr12.30 Million
Gross Profit Skr-8.03 Million Skr11.20 Million Skr6.92 Million Skr-13.64 Million Skr-6.45 Million
Research & Development Skr137.00K
SG&A Skr43.46 Million
Total Operating Expenses Skr32.22 Million Skr21.52 Million Skr53.46 Million Skr18.61 Million Skr15.85 Million
Operating Income Skr-8.03 Million Skr-10.32 Million Skr-46.54 Million Skr-13.78 Million Skr-6.45 Million
EBITDA Skr-4.12 Million Skr-8.45 Million Skr-44.98 Million Skr-7.59 Million Skr-38.60 Million
EBIT Skr-8.03 Million Skr-10.04 Million Skr-46.46 Million Skr-13.83 Million Skr-58.56 Million
Interest Expense Skr33.00K Skr81.00K Skr92.00K Skr303.00K
Income Before Tax Skr-8.21 Million Skr-10.12 Million Skr-46.55 Million Skr-14.14 Million Skr-58.56 Million
Income Tax Expense Skr-169.00K Skr36.00K Skr32.47 Million Skr3.69 Million Skr-19.96 Million
Net Income Skr-8.04 Million Skr-10.16 Million Skr-46.55 Million Skr-17.82 Million Skr-58.56 Million

Nosa Med AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Nosa Med AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr64.71 Million Skr20.70 Million Skr33.08 Million Skr21.67 Million Skr40.09 Million
Total Current Assets Skr27.67 Million Skr12.66 Million Skr7.82 Million Skr6.55 Million Skr11.02 Million
Cash & Equivalents
Short-term Investments
Net Receivables Skr5.57 Million Skr3.77 Million Skr3.59 Million Skr1.32 Million Skr614.00K
Inventory Skr4.80 Million Skr4.13 Million Skr2.62 Million Skr2.47 Million
Property, Plant & Equipment
Goodwill Skr9.30 Million Skr0.00
Total Liabilities Skr23.65 Million Skr4.14 Million Skr6.33 Million Skr3.33 Million Skr980.00K
Total Current Liabilities Skr13.49 Million Skr3.91 Million Skr5.31 Million Skr2.76 Million Skr980.00K
Long-term Debt Skr0.00 Skr367.00K Skr804.00K
Net Debt Skr-16.58 Million Skr-3.31 Million Skr692.00K Skr-10.89 Million Skr-1.36 Million
Total Stockholder Equity Skr41.06 Million Skr16.56 Million Skr26.75 Million Skr6.70 Million Skr39.10 Million
Retained Earnings Skr-111.54 Million Skr-103.50 Million Skr-93.34 Million Skr-46.79 Million Skr-454.93 Million

Nosa Med AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Nosa Med AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-6.39 Million Skr-10.03 Million Skr-17.50 Million Skr-6.93 Million Skr-6.21 Million
Capital Expenditures Skr6.39 Million Skr4.62 Million Skr855.00K Skr61.00K Skr10.60 Million
Free Cash Flow Skr-6.39 Million Skr-14.70 Million Skr-18.35 Million Skr-5.19 Million Skr-16.81 Million
Investing Cash Flow Skr-12.40 Million Skr-4.71 Million Skr14.55 Million Skr-61.00K Skr-52.20 Million
Financing Cash Flow Skr31.96 Million Skr17.81 Million Skr1.61 Million Skr5.29 Million Skr-119.00K
Dividends Paid
Stock-Based Compensation Skr180.00K Skr366.00K
Depreciation Skr3.91 Million Skr1.88 Million Skr1.49 Million Skr6.15 Million Skr19.96 Million
Change in Cash Skr12.98 Million Skr3.13 Million Skr-1.34 Million Skr-7.88 Million Skr-77.41 Million

Nosa Med AB Earnings History — EPS Actual vs. Analyst Estimates

Track Nosa Med AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 16, 2026 0.00
Nov 10, 2025 -0.02
Aug 22, 2025 -0.01 0.00
May 15, 2025 -0.01 -0.01 +0.00%
Feb 14, 2025 -0.01 0.00
Nov 08, 2024 -0.01
Aug 23, 2024 -0.01
May 10, 2024 -0.02